Medtronic Balans Gezondheid
Financiële gezondheid criteriumcontroles 3/6
Medtronic heeft een totaal eigen vermogen van $48.2B en een totale schuld van $27.8B, wat de schuld-eigenvermogensverhouding op 57.8% brengt. De totale activa en totale passiva bedragen respectievelijk $89.7B en $41.6B. De EBIT Medtronic is $6.4B waardoor de rentedekking 45.5 is. Het heeft contanten en kortetermijnbeleggingen van $7.8B.
Belangrijke informatie
57.8%
Verhouding schuld/eigen vermogen
US$27.81b
Schuld
| Rente dekkingsratio | 45.5x |
| Contant | US$7.84b |
| Aandelen | US$48.16b |
| Totaal verplichtingen | US$41.59b |
| Totaal activa | US$89.75b |
Recente financiële gezondheidsupdates
Medtronic (NYSE:MDT) Seems To Use Debt Quite Sensibly
Sep 05
These 4 Measures Indicate That Medtronic (NYSE:MDT) Is Using Debt Reasonably Well
May 22Does Medtronic (NYSE:MDT) Have A Healthy Balance Sheet?
Jan 16Medtronic (NYSE:MDT) Seems To Use Debt Quite Sensibly
Oct 04Recent updates
Medtronic (NYSE:MDT) Hasn't Managed To Accelerate Its Returns
Nov 08Medtronic: Undervalued But Trapped In Slow Growth (Rating Downgrade)
Oct 31Is It Time To Consider Buying Medtronic plc (NYSE:MDT)?
Oct 13Medtronic: Undervalued Dividend Aristocrat With High Margins
Oct 10An Intrinsic Calculation For Medtronic plc (NYSE:MDT) Suggests It's 33% Undervalued
Sep 30Medtronic (NYSE:MDT) Boosts FY 2025 Guidance Amid Strong Q1 Earnings and Strategic Share Buybacks
Sep 16Medtronic: An Undervalued Stock With Durable Competitive Advantages
Sep 16Medtronic (NYSE:MDT) Seems To Use Debt Quite Sensibly
Sep 05Medtronic: Is The Company Back?
Aug 26Medtronic: Still A Buy Before Earnings
Aug 17Returns At Medtronic (NYSE:MDT) Appear To Be Weighed Down
Aug 08Medtronic: An Out Of Favor Healthcare Stock With A Pulse On Profit Potential
Jul 16At US$77.06, Is Medtronic plc (NYSE:MDT) Worth Looking At Closely?
Jul 11Medtronic (NYSE:MDT) Is Paying Out A Larger Dividend Than Last Year
Jun 27Medtronic: Why I Disagree With The Crowd
Jun 14Medtronic's (NYSE:MDT) Upcoming Dividend Will Be Larger Than Last Year's
Jun 10Medtronic: Net Income Could Fall $3.38B, The Stock Would Still Be Undervalued
May 27Medtronic (NYSE:MDT) Has Announced That It Will Be Increasing Its Dividend To $0.70
May 26These 4 Measures Indicate That Medtronic (NYSE:MDT) Is Using Debt Reasonably Well
May 22Medtronic Stock Looks Promising Before Fiscal Q4 2024 Release
May 13Is Medtronic plc (NYSE:MDT) Trading At A 20% Discount?
May 0135% Undervalued? Medtronic's Future Looks Very Bright
Apr 12Medtronic: Buy This Dividend Aristocrat Diamond In The Rough Now
Mar 27Medtronic: Undervalued Medical Devices Stock With Robust Demand And Strong Dividend Growth
Mar 11Medtronic (NYSE:MDT) Has Announced A Dividend Of $0.69
Mar 11Medtronic: Its Recent Beat Proves That It Continues To Be A Rock
Feb 25Results: Medtronic plc Beat Earnings Expectations And Analysts Now Have New Forecasts
Feb 22Medtronic: A Good Choice For Dividend Investors Seeking For Low Volatility
Feb 16A Look At The Fair Value Of Medtronic plc (NYSE:MDT)
Jan 31Does Medtronic (NYSE:MDT) Have A Healthy Balance Sheet?
Jan 16Medtronic Stock's Rally Is Set To Continue
Jan 11Medtronic plc's (NYSE:MDT) Price Is Out Of Tune With Earnings
Dec 29Medtronic's (NYSE:MDT) Dividend Will Be $0.69
Dec 12Medtronic: The GLP-1 Drug Headwinds Are Overblown
Dec 103.5% Yield And Over 15% Annual Return Potential - I Really Like Medtronic
Nov 28Returns On Capital At Medtronic (NYSE:MDT) Have Hit The Brakes
Nov 19Medtronic: 3 Key Issues To Consider Ahead Of Fiscal Q2 2024 Earnings
Nov 17Medtronic Faces Potential Decline Despite Financial Strength
Oct 29An Intrinsic Calculation For Medtronic plc (NYSE:MDT) Suggests It's 21% Undervalued
Oct 19Medtronic (NYSE:MDT) Seems To Use Debt Quite Sensibly
Oct 04Medtronic: Improved Guidance, Historically Cheap P/E, Yield Reaches 3.5%
Sep 27Medtronic (NYSE:MDT) Is Paying Out A Dividend Of $0.69
Sep 18Medtronic: The Tide Is Turning
Aug 24Medtronic (NYSE:MDT) Is Paying Out A Dividend Of $0.69
Aug 21Analyse van de financiële positie
Kortlopende schulden: De korte termijn activa ( $21.9B ) MDT } overtreffen de korte termijn passiva ( $10.3B ).
Langlopende schulden: De kortetermijnactiva van MDT ( $21.9B ) dekken de langetermijnschulden ( $31.3B ) niet.
Schuld/ eigen vermogen geschiedenis en analyse
Schuldniveau: De netto schuld/eigen vermogen ratio ( 41.5% ) MDT wordt als hoog beschouwd.
Schuld verminderen: De schuld/eigen vermogen-ratio van MDT is de afgelopen 5 jaar gestegen van 51.9% naar 57.8%.
Schuldendekking: De schuld van MDT wordt goed gedekt door de operationele kasstroom ( 24.8% ).
Rentedekking: De rentebetalingen op de schuld van MDT worden goed gedekt door EBIT ( 45.5 x dekking).